HeartFlow Analysis vs DeepTek CXR Analyzer
AI Verdict
Choose HeartFlow Analysis if…
Choose HeartFlow Analysis if you require a highly detailed, non-invasive assessment of coronary artery disease (CAD) severity and its functional impact. This tool is ideal for creating personalized 3D models from standard CT scans, providing insights into blood flow dynamics (FFRct) and plaque characteristics to guide treatment decisions without invasive procedures.
View HeartFlow Analysis →Choose DeepTek CXR Analyzer if…
Choose DeepTek CXR Analyzer if your primary need is to enhance the efficiency and accuracy of routine chest X-ray interpretations across a wide range of pathologies. This AI-powered CADe solution excels at automatically detecting and highlighting suspicious regions in lung, pleural, and cardiac areas, significantly reducing radiologist workload and accelerating diagnostic workflows for high-volume screening.
View DeepTek CXR Analyzer →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | HeartFlow Analysis | DeepTek CXR Analyzer |
|---|---|---|
| Pricing | Contact vendor for pricing | Global access pricing available for eligible public sector and not-for-profit healthcare providers in 138 low- and middle-income countries, offering unlimited ai analyses per connected x-ray unit, installation, user training, product updates, maintenance, and technical support via an annual subscription. |
| Deployment | Cloud-based (AWS) | On-premise and Cloud offerings. The solution supports online, offline, and hybrid deployment. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
DeepTek CXR AnalyzerDeepTek CXR Analyzer explicitly quantifies significant workflow improvements for radiologists, claiming a 30-50% reduction in workload and a 2x-3x boost in productivity through seamless PACS integration and intelligent scan segregation. While HeartFlow also aims for workflow efficiency with a 25% reduction in CCTA read times, DeepTek's direct impact on high-volume chest X-ray interpretation suggests a more immediate and widespread enhancement to daily radiologist usability.
Clinical Value
HeartFlow AnalysisHeartFlow Analysis demonstrates superior clinical value with extensive evidence of improved patient outcomes, including a 14% relative reduction in cardiovascular mortality and an 8% reduction in all-cause mortality, as well as significantly reducing unnecessary invasive procedures. Its established Category I CPT codes and CMS payment rates further underscore its recognized integration into standard clinical care pathways. DeepTek CXR Analyzer, while FDA-cleared and showing strong diagnostic performance, does not present as comprehensive a body of evidence on direct patient outcome improvement or established reimbursement pathways.
Pricing & Value
HeartFlow AnalysisHeartFlow Analysis offers a strong value proposition through established Category I CPT codes and CMS payment rates, which de-risk financial investment for healthcare providers and ensure reimbursement. Multiple studies also demonstrate significant cost savings per patient (e.g., $1,394 USD per patient over two years) and improved cost-effectiveness compared to traditional diagnostic pathways. DeepTek's pay-per-use model and claims of cost-effectiveness for specific applications like TB screening are noted, but HeartFlow's established reimbursement and broader economic impact studies provide a clearer and more substantial financial value for healthcare systems.
Enterprise Readiness
DeepTek CXR AnalyzerDeepTek CXR Analyzer offers greater enterprise readiness due to its flexible deployment options, supporting both cloud and on-premise installations, which caters to diverse IT infrastructure and data governance requirements. Its seamless DICOM-based PACS integration, compatibility with various X-ray modalities, and ability to function offline on basic hardware further enhance its adaptability for a broader range of enterprise environments, including those with limited resources.
Innovation
HeartFlow AnalysisHeartFlow Analysis demonstrates a higher degree of innovation by utilizing advanced computational fluid dynamics (CFD) and AI to create personalized 3D models of coronary arteries and derive Fractional Flow Reserve from CT (FFRct). This approach provides functional assessment of coronary artery disease non-invasively, a significant advancement beyond traditional anatomical imaging. DeepTek CXR Analyzer, while a comprehensive CADe solution for chest X-rays, represents a more established application of AI in radiology.
Support & Docs
HeartFlow AnalysisHeartFlow provides a comprehensive and explicitly detailed support program, including hands-on training, technology integration assistance, expert coding and reimbursement support, peer mentorship, and a dedicated clinical and technical support team. While DeepTek mentions a 'Resources Hub' and installation guides, HeartFlow's offerings appear more structured and extensive, directly addressing the multifaceted needs of enterprise clients for successful adoption and ongoing operation.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | HeartFlow Analysis | DeepTek CXR Analyzer |
|---|---|---|
| Tool Name | HeartFlow Analysis | DeepTek CXR Analyzer |
| Company | HeartFlow | DeepTek Medical Imaging Pvt |
| Description | Commercial-stage medical technology company providing software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD) by creating personalized 3D models of patients' coronary arteries from standard CT scans. | FDA-cleared AI-powered CADe solution for chest X-ray analysis, designed to assist radiologists by automatically detecting and highlighting suspicious regions across lung, pleural, and cardiac pathologies, significantly improving workflow efficiency and diagnostic accuracy. |
| Primary Focus | Coronary Artery Disease (CAD) diagnosis and management via 3D models from CT scans | Chest X-ray analysis for detection of lung, pleural, and cardiac pathologies |
| Key Features | AI-powered 3D modeling of coronary arteries, Fractional Flow Reserve derived from CT (FFRct) analysis, Plaque Analysis (quantification and characterization), Roadmapu2122 Analysis for CCTA reading, Non-invasive diagnostic assessment, Personalized patient insights, Computational Fluid Dynamics (CFD) for blood flow simulation, High diagnostic accuracy | AI-Powered Computer-Assisted Detection (CADe) for Chest X-rays, Detection of 28 findings covering lung, pleural, cardiac pathologies, and hardware, Automatic identification, categorization, and highlighting of suspicious regions of interest (ROIs), Seamless DICOM-based PACS integration (on-premise or cloud), Intelligent segregation of scans into 'AI Finding-Negative' and 'AI Finding-Positive', Reduces radiologist workload by 30-50% and boosts productivity by 2x-3x, Generates secondary capture DICOM with AI output for easy interpretation, Compatible with various X-ray modalities (hospital, mobile, portable, handheld) |
Videos
Demos, reviews, and walkthroughs featuring HeartFlow Analysis and DeepTek CXR Analyzer.